NCT07614516

Brief Summary

Epidural analgesia is the gold standard for controlling labour pain. However, labour pain happens during neuraxial analgesia, due to anaesthetic, obstetric, maternal factors. The investigators hypothesized that relevant variables, able to predict the local anaesthetic (LA) requirement during labour, can be identified at admission and each parturient may therefore be accordingly classified in "low-requirement" and "high-requirement". In this way, a predictive score may be developed, and the analgesic regimen may be matched to the individual patient, thus ensuring a timely and appropriate treatment of patients likely to require higher doses of LA, while minimizing potentially side effects of excessive treatment in the low-dose group.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12,500

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Jun 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Jun 2026Oct 2026

First Submitted

Initial submission to the registry

May 8, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 29, 2026

Completed
15 days until next milestone

Study Start

First participant enrolled

June 13, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2026

Last Updated

May 29, 2026

Status Verified

May 1, 2026

Enrollment Period

4 months

First QC Date

May 8, 2026

Last Update Submit

May 22, 2026

Conditions

Keywords

Machine LearningAnesthesia, ObstetricAnesthesia, EpiduralAnesthetics, Local

Outcome Measures

Primary Outcomes (1)

  • Machine-learning algorithm able to predict the LA consumption

    To develop a machine-learning algorithm able to predict the mean hourly cumulative LA consumption administered via the epidural catheter from the catheter placement up to delivery, expressed as time-weighted LA consumption per hour (mg/h) in patients receiving top-up analgesia or the need for adjunctive rescue LA boluses in patients receiving PIEB (Programmed Intermittent Epidural Bolus) analgesia.

    From the epidural catheter placement to delivery.

Secondary Outcomes (23)

  • Clinical score

    At admission in the Labour Suite and before the epidural catheter is placed

  • Time-dependent AUC of LA manual boluses

    From epidural catheter placement to delivery.

  • Total LA consumption

    From epidural catheter placement to delivery.

  • Ratio of time to first bolus demand to duration of labor

    From epidural catheter placement to delivery.

  • Total demand of LA boluses

    From epidural catheter placement to delivery.

  • +18 more secondary outcomes

Study Arms (1)

All parturients between January 2020 and March 2026

All parturients who delivered via vaginal route or intrapartum caesarean section and received neuraxial analgesia (epidural analgesia (EA) or combined spinal-epidural \[CSE\] analgesia or dural puncture epidural (DPE)) in Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, between January 1st, 2020 and March 01th, 2026 (including follow-up data), meeting the inclusion criteria. Labour analgesia was maintained through manual top-up boluses or PIEB (Programmed Intermittent Epidural Bolus).

Other: Machine-learning prediction model

Interventions

A machine-learning prediction model will be developed to anticipate the parturient's requirement of LA at admission in the Labour Suite, according to demographic, obstetric and anaesthetic features ongoing before administration of the first epidural bolus.

All parturients between January 2020 and March 2026

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All parturients who delivered via vaginal route or intrapartum caesarean section and received neuraxial analgesia (epidural analgesia (EA) or combined spinal-epidural \[CSE\] analgesia or dural puncture epidural (DPE)) in Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, between January 1st, 2020 and March 01th, 2026 (including follow-up data), meeting the inclusion criteria.

You may qualify if:

  • Parturients receiving neuraxial analgesia for labour, as clinical practice

You may not qualify if:

  • Planned caesarean delivery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

Rome, RM, 00168, Italy

Location

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 8, 2026

First Posted

May 29, 2026

Study Start

June 13, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

October 31, 2026

Last Updated

May 29, 2026

Record last verified: 2026-05

Locations